Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Garris

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Science (New York, N.Y.)|March 19, 2016
SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactionsFerdinando Pucci, Christopher Garris, Charles P Lai, et al.
Cell|March 31, 2023
A neutrophil response linked to tumor control in immunotherapyJeremy Gungabeesoon, Nicolas A Gort-Freitas, Máté Kiss, et al.
Immunity|February 14, 2016
Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade TherapyChristina Pfirschke, Camilla Engblom, Steffen Rickelt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2020
Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent MelanomaAlain P Algazi, Christopher G Twitty, Katy K Tsai, et al.
Nature|August 23, 2023
Non-cell-autonomous cancer progression from chromosomal instabilityJun Li, Melissa J Hubisz, Ethan M Earlie, et al.
Science (New York, N.Y.)|December 2, 2017
Osteoblasts remotely supply lung tumors with cancer-promoting SiglecF<sup>high</sup> neutrophilsCamilla Engblom, Christina Pfirschke, Rapolas Zilionis, et al.
Science Immunology|July 3, 2021
Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapyMarie Siwicki, Nicolas A Gort-Freitas, Marius Messemaker, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Science (New York, N.Y.)|March 19, 2016
SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactionsFerdinando Pucci, Christopher Garris, Charles P Lai, et al.
Cell|March 31, 2023
A neutrophil response linked to tumor control in immunotherapyJeremy Gungabeesoon, Nicolas A Gort-Freitas, Máté Kiss, et al.
Immunity|February 14, 2016
Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade TherapyChristina Pfirschke, Camilla Engblom, Steffen Rickelt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2020
Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent MelanomaAlain P Algazi, Christopher G Twitty, Katy K Tsai, et al.
Nature|August 23, 2023
Non-cell-autonomous cancer progression from chromosomal instabilityJun Li, Melissa J Hubisz, Ethan M Earlie, et al.
Science (New York, N.Y.)|December 2, 2017
Osteoblasts remotely supply lung tumors with cancer-promoting SiglecF<sup>high</sup> neutrophilsCamilla Engblom, Christina Pfirschke, Rapolas Zilionis, et al.
Science Immunology|July 3, 2021
Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapyMarie Siwicki, Nicolas A Gort-Freitas, Marius Messemaker, et al.
Pageof 2